Skip to Main Content

Paper Details

Inflammatory and infectious upper respiratory diseases associate with 41 genomic loci and type 2 inflammation.
Nat Commun
1
2023
Inflammatory and infectious upper respiratory diseases, Upper respiratory diseases, asthma, atopic dermatitis, autoimmune diseases, autoimmune hypothyroidism, diseases of the sinonasal tract, pharynx and larynx, gene pathways, genetic loci, genome-wide significant loci, genomic loci, immune-mediated diseases, immune-mediated disorders, immune-related diseases, inflammatory bowel diseases, non, participants, pharyngeal disease, pharyngeal disease loci, psoriasis, rheumatoid arthritis, sinonasal and pharyngeal diseases, sinonasal disease, sinonasal disease loci, sinonasal or pharyngeal diseases, type 2 high inflammation, type 2 inflammation, upper respiratory diseases
Author NameAffiliation
Elmo SaarentausInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Elmo SaarentausUniversity of Helsinki and Helsinki University Hospital
Aki S HavulinnaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Aki S HavulinnaFinnish Institute for Health and Welfare
Matti PirinenInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Matti PirinenUniversity of Helsinki
Matti PirinenUniversity of Helsinki
Mitja I KurkiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Mitja I KurkiMassachusetts General Hospital
Mitja I KurkiStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Samuli RipattiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Samuli RipattiUniversity of Helsinki
Samuli RipattiBroad Institute of MIT and Harvard
Mark J DalyInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Mark J DalyMassachusetts General Hospital
Mark J DalyBroad Institute of MIT and Harvard
Mark J DalyInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Mark J DalyMassachusetts General Hospital
Mark J DalyBroad Institute of MIT and Harvard
Aarno PalotieInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Aarno PalotieStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Aarno PalotieMassachusetts General Hospital
  • 1 - 22

Datasets

Release 1.2